Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards

AMD’s Lisa Su, Fei-Fei Li Discuss $8.2 Billion World Labs Deal
08:35

Former Disney CEO Bob Chapek Talks His Time at Disney
26:37

NEC's Kevin Hassett Talks US Economic Goals
21:45